We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Syneron Medical Ltd. - Ordinary Shares | NASDAQ:ELOS | NASDAQ | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.00 | 10.95 | 11.35 | 0.00 | 01:00:00 |
Ordinary Shares
|
M87245102
|
(Title of Class of Securities)
|
(CUSIP Number)
|
1
|
NAME OF REPORTING PERSONS
Shimon Eckhouse
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a)
o
|
||
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS (See Instructions)
PF
|
||
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|
8
|
SHARED VOTING POWER
0
|
||
9
|
SOLE DISPOSITIVE POWER
0
|
||
10
|
SHARED DISPOSITIVE POWER
0
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See instructions)
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
|
||
14
|
TYPE OF REPORTING PERSON (See instructions)
IN
|
1
|
NAME OF REPORTING PERSONS
Musia Eckhouse
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a)
o
(b)
o
|
||
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS (See Instructions)
OO
|
||
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|
8
|
SHARED VOTING POWER
0
|
||
9
|
SOLE DISPOSITIVE POWER
0
|
||
10
|
SHARED DISPOSITIVE POWER
0
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See instructions)
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
|
||
14
|
TYPE OF REPORTING PERSON (See instructions)
IN
|
1
|
NAME OF REPORTING PERSONS
European High-Tech Capital, S.A.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a)
o
(b)
o
|
||
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
||
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Nevis, West Indies
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|
8
|
SHARED VOTING POWER
0
|
||
9
|
SOLE DISPOSITIVE POWER
0
|
||
10
|
SHARED DISPOSITIVE POWER
0
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See instructions)
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
|
||
14
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
(a), (b) |
As of the date of this filing, European, Dr. Shimon Eckhouse and Mrs. Musia Eckhouse are each beneficial owner of 0 Ordinary Shares, representing 0.0% of the total outstanding Ordinary Shares, and have the shared power to vote or direct the vote of, and the shared power to dispose of or direct the disposition of, 0 Ordinary Shares, representing 0.0% of the total outstanding Ordinary Shares.
|
(c)
|
The Reporting Persons have not effected any transaction in Ordinary Shares during the 60 days prior to the filing of this Schedule 13D, except as set forth herein.
|
(d)
|
Not applicable.
|
(e)
|
On June 17, 2017, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the Ordinary Shares.
|
Item 6. |
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
1 |
Termination of the Nominee Agreement dated December 22, 2008 (incorporated herein by reference to Exhibit 1 to the Schedule 13D filed by the Reporting Persons on December 22, 2011).
|
2 |
Joint Filing Agreement, dated December 22, 2011, among Dr. Shimon Eckhouse, Mrs. Musia Eckhouse and European (incorporated herein by reference to Exhibit 2 to the Schedule 13D filed by the Reporting Persons on December 22, 2011).
|
3 |
Voting Agreement, dated as of April 2, 2017, by and among Lupert Ltd. and Dr. Shimon Eckhouse
(incorporated herein by reference to Exhibit 99.2 to the Form 6-K filed by Syneron on April 3, 2017).
|
European High-Tech Capital S.A.
/s/ Michael Eden By: Michael Eden Title: CFO |
||
Dr. Shimon Eckhouse
/s/
Shimon Eckhouse
Mrs. Musia Eckhouse
/
s/
Musia Eckhouse
|
1 Year Syneron Medical Ltd. - Ordinary Shares Chart |
1 Month Syneron Medical Ltd. - Ordinary Shares Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions